Literature DB >> 7551996

Gastric juice epidermal growth factor concentration and Helicobacter pylori in patients with duodenal ulcer.

A M Tunio1, J Holton, M Hobsley.   

Abstract

The level of epidermal growth factor (EGF) was measured in the basal and maximally stimulated gastric juice of 20 control subjects and 20 patients each with duodenal ulcer and non-ulcer dyspepsia. Basal gastric juice was analysed for ammonia and urea concentrations, and the [ammonia]3/[urea] ratio was used to show Helicobacter pylori status, as was the [13C]urea breath test in nine controls. There was complete concordance in the nine controls between the two methods for determining H. pylori status. Twenty-five subjects were H. pylori positive (seven with duodenal ulcer, nine with non-ulcer dyspepsia, nine controls) and 35 H. pylori negative (13, 11 and 11 respectively). In H. pylori-positive subjects, the median EGF concentrations in the stimulated secretion of patients with duodenal ulcer and without (non-ulcer dyspepsia and controls combined) were 46.7 and 18.0 ng/ml (P < 0.001), and in H. pylori-negative subjects were 40.0 and 26.5 ng/ml respectively (P < 0.01). There was no difference in EGF concentration between controls and subjects with non-ulcer dyspepsia irrespective of H. pylori status. Lack of EGF is unlikely to be a cause of duodenal ulcer. The increased EGF concentration in patients with ulcer bore no relationship to the H. pylori status of the individual. If this bacterium causes duodenal ulcer, it is not via a reduction in EGF concentration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551996     DOI: 10.1002/bjs.1800820917

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  Helicobacter pylori infection and gastrointestinal hormones:a review.

Authors:  Xiang-Qian Huang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.